Author

Ludmila A. Kryzhanovskaya

Observed names: Ludmila A Kryzhanovskaya, Ludmila Kryzhanovskaya

Institution: Intercept Pharmaceuticals (United States)

Observed institutions: University of Minnesota, Eli Lilly (United States), University of Virginia, Intercept Pharmaceuticals (United States)

OpenAlex ID: A5110187641

Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania

2007 · Mauricio Tohen, Ludmila Kryzhanovskaya, et al. · American Journal of Psychiatry · 318

A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia

2011 · Bruce J. Kinon, Lu Zhang, et al. · Journal of Clinical Psychopharmacology · 256

Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial

2008 · Ludmila Kryzhanovskaya, S. Charles Schulz, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 169

The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research

2016 · Victoria A. Reed, Jan K. Buitelaar, et al. · CNS Drugs · 113

Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania

2008 · Mauricio Tohen, Eduard Vieta, et al. · The Journal of Clinical Psychiatry · 87

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder

2011 · Mary C. Zanarini, S. Charles Schulz, et al. · The Journal of Clinical Psychiatry · 83

Olanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes

2008 · Mauricio Tohen, Charles L. Bowden, et al. · The British Journal of Psychiatry · 75

PDF

A 28-Week, Randomized, Double-Blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

2009 · John M. Kane, Olawale Osuntokun, et al. · The Journal of Clinical Psychiatry · 66

Suicidal Behavior in Patients with Adjustment Disorders

2001 · Ludmila Kryzhanovskaya, Randolph Canterbury · Crisis · 66

Comparison of Long-Term (At Least 24 Weeks) Weight Gain and Metabolic Changes Between Adolescents and Adults Treated with Olanzapine

2012 · Ludmila A. Kryzhanovskaya, Wen Xu, et al. · Journal of Child and Adolescent Psychopharmacology · 49

Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials

2006 · Patrizia A. Cavazzoni, Paul H. Berg, et al. · The Journal of Clinical Psychiatry · 49

Diabetes mellitus and antipsychotic treatment in the United Kingdom

2005 · Christopher Carlson, Kenneth Hornbuckle, et al. · European Neuropsychopharmacology · 49

The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder

2009 · Ludmila A. Kryzhanovskaya, Carol K. Robertson-Plouch, et al. · The Journal of Clinical Psychiatry · 43

A Review of Treatment-Emergent Adverse Events During Olanzapine Clinical Trials in Elderly Patients With Dementia

2006 · Ludmila A. Kryzhanovskaya, Dilip V. Jeste, et al. · The Journal of Clinical Psychiatry · 42

Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long‐acting injection versus oral olanzapine

2011 · David P. McDonnell, Ludmila A. Kryzhanovskaya, et al. · Human Psychopharmacology Clinical and Experimental · 35

Early Predictors of Weight Gain Risk During Treatment with Olanzapine:Analysis of Pooled Data from 58 Clinical Trials

2025 · Ilya Lipkovich, Jennie G. Jacobson, et al. · Psychopharmacology Bulletin · 21

Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia

2013 · Cheryl Enger, Meghan E. Jones, et al. · International Journal of Adolescent Medicine and Health · 21

Incarcerated Adolescents' Distress and Suicidality in Relation to Parental Bonding Styles

1999 · Elizabeth L McGarvey, Ludmila A Kryzhanovskaya, et al. · Crisis · 21

Cross-sectional Comparison of Fasting Lipids in Normoglycemic Patients With Schizophrenia During Chronic Treatment With Olanzapine, Risperidone, or Typical Antipsychotics

2006 · Thomas A. Hardy, Eva Marquez, et al. · Journal of Clinical Psychopharmacology · 18

Time-to-onset and -resolution of adverse events before/after atomoxetine discontinuation in adult patients with ADHD

2015 · Himanshu Upadhyaya, Yoko Tanaka, et al. · Postgraduate Medicine · 15

Suicidal Behavior in the Ukraine, 1988-1998

1999 · Ludmila Kryzhanovskaya, Galina Pilyagina · Crisis · 14

Olanzapine Versus Chlorpromazine in the Treatment of Schizophrenia

2007 · Martin Dossenbach, Tamás Treuer, et al. · Journal of Clinical Psychopharmacology · 10

A 28-week, Randomized, Double-blind Study of Olanzapine Versus Aripiprazole in the Treatment of Schizophrenia

2008 · John M. Kane, Olawale Osuntokun, et al. · Schizophrenia Research · 9

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INT ‐787, a Novel Farnesoid X Receptor Agonist, in Healthy Volunteers: A Phase 1 Trial

2025 · Thomas Capozza, Jennifer Burkey, et al. · Clinical and Translational Science · 5

PDF

Adverse Events in Healthy Subjects Exposed to Single and Multiple Doses of LY2140023 Monohydrate

2012 · Mosun Ayan-Oshodi, Eshetu T. Wondmagegnehu, et al. · Journal of Clinical Psychopharmacology · 4

Works count: 32

Citation count: 1,647

H-index: 18

I10-index: 22